Sanara MedTech Inc.
SMTI
$16.96
-$1.05-5.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.72% | 21.51% | 28.14% | 26.42% | 48.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.72% | 21.51% | 28.14% | 26.42% | 48.70% |
| Cost of Revenue | -16.66% | -5.91% | -3.55% | -2.91% | 25.78% |
| Gross Profit | 6.71% | 24.29% | 31.64% | 29.75% | 51.28% |
| SG&A Expenses | -0.72% | 14.11% | 13.69% | 32.41% | 23.78% |
| Depreciation & Amortization | 260.91% | -12.34% | 0.79% | 1.72% | -83.08% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.74% | 11.96% | 12.16% | 26.72% | 18.46% |
| Operating Income | 4.49% | 277.80% | 98.92% | -30.21% | 226.88% |
| Income Before Tax | -218.47% | 562.33% | 42.81% | -96.08% | 456.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -218.47% | 562.33% | 42.81% | -96.08% | 456.21% |
| Earnings from Discontinued Operations | 79.67% | -1,066.35% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -41.18% | -84.13% | -99.43% | -100.00% |
| Net Income | -4.63% | -964.15% | 42.51% | -99.93% | -548.65% |
| EBIT | 4.49% | 277.80% | 98.92% | -30.21% | 226.88% |
| EBITDA | 20.58% | 91.55% | 160.39% | -94.23% | 371.82% |
| EPS Basic | -5.38% | -948.32% | 43.48% | -96.47% | -537.10% |
| Normalized Basic EPS | -48.67% | 564.62% | 43.52% | -92.03% | 158.34% |
| EPS Diluted | -5.38% | -914.87% | 43.48% | -96.47% | -537.10% |
| Normalized Diluted EPS | -48.67% | 549.23% | 43.52% | -92.03% | 158.34% |
| Average Basic Shares Outstanding | -0.68% | 1.52% | 1.70% | 1.79% | 1.78% |
| Average Diluted Shares Outstanding | -0.68% | 4.97% | 1.70% | 1.79% | 1.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |